Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 562

The DOI matches its Crossref record; 19 of the 19 references it cites were found in a registry or an index.

Spatial maps of prostate cancer transcriptomes reveal an unexplored landscape of heterogeneity

Open access
Berglund, Emelie, Maaskola, Jonas, Schultz, Niklas, Friedrich, Stefanie, Marklund, Maja, Bergenstråhle, Joseph, Tarish, Firas, Tanoglidi, Anna, Vickovic, Sanja, Larsson, Ludvig, Salmén, Fredrik, Ogris, Christoph, Wallenborg, Karolina, Lagergren, Jens, Ståhl, Patrik, Sonnhammer, Erik, Helleday, Thomas, Lundeberg, Joakim·2018·Nature Communications

Abstract

Intra-tumor heterogeneity is one of the biggest challenges in cancer treatment today. Here we investigate tissue-wide gene expression heterogeneity throughout a multifocal prostate cancer using the spatial transcriptomics (ST) technology. Utilizing a novel approach for deconvolution, we analyze the transcriptomes of nearly 6750 tissue regions and extract distinct expression profiles for the different tissue components, such as stroma, normal and PIN glands, immune cells and cancer. We distinguish healthy and diseased areas and thereby provide insight into gene expression changes during the progression of prostate cancer. Compared to pathologist annotations, we delineate the extent of cancer foci more accurately, interestingly without link to histological changes. We identify gene expression gradients in stroma adjacent to tumor regions that allow for re-stratification of the tumor microenvironment. The establishment of these profiles is the first step towards an unbiased view of prostate cancer and can serve as a dictionary for future studies.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/s41467-018-04724-5

Cites

19 of 19 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 19 references

Research works printed but not linked: 54

  1. Bray, F., Ren, J.-S., Masuyer, E. & Ferlay, J. Global estimates of cancer prevalence for 27 sites in the adult population in 2008. Int. J. Cancer 132, 1133–1145 (2013). · DOI · Paper page
  2. Lindberg, J. et al. Exome sequencing of prostate cancer supports the hypothesis of independent tumour origins. Eur. Urol. 63, 347–353 (2013). · DOI · Paper page
  3. Cooper, C. S. et al. Analysis of the genetic phylogeny of multifocal prostate cancer identifies multiple independent clonal expansions in neoplastic and morphologically normal prostate tissue. Nat. Genet. 47, 367–372 (2015). · DOI · Paper page
  4. Gupta, G. P. & Massagué, J. Cancer metastasis: building a framework. Cell 127, 679–695 (2006). · DOI · Paper page
  5. Hong, M. K. H. et al. Tracking the origins and drivers of subclonal metastatic expansion in prostate cancer. Nat. Commun. 6, 6605 (2015). · DOI · Paper page
  6. Gundem, G. et al. The evolutionary history of lethal metastatic prostate cancer. Nature 520, 353–357 (2015). · DOI · Paper page
  7. Morrissy, A. S. et al. Spatial heterogeneity in medulloblastoma. Nat. Genet. 49, 780–788 (2017). · DOI
  8. Kim, K.-T. et al. Single-cell mRNA sequencing identifies subclonal heterogeneity in anti-cancer drug responses of lung adenocarcinoma cells. Genome Biol. 16, 127 (2015). · DOI · Paper page
  9. Junker, J. P. & van Oudenaarden, A. Single-cell transcriptomics enters the age of mass production. Mol. Cell 58, 563–564 (2015). · DOI
  10. Achim, K. et al. High-throughput spatial mapping of single-cell RNA-seq data to tissue of origin. Nat. Biotechnol. 33, 503–509 (2015). · DOI · Paper page
  11. Lee, J. H. et al. Highly multiplexed subcellular RNA sequencing in situ. Science 343, 1360–1363 (2014). · DOI · Paper page
  12. Epstein, J. I. et al. The 2014 International Society of Urological Pathology (ISUP) Consensus Conference on Gleason grading of prostatic carcinoma: definition of grading patterns and proposal for a new grading system. Am. J. Surg. Pathol. 40, 244–252 (2016). · DOI · Paper page
  13. Gordetsky, J. & Epstein, J. Grading of prostatic adenocarcinoma: current state and prognostic implications. Diagn. Pathol. 11, 25 (2016). · DOI · Paper page
  14. Whitaker, H. C. et al. The rs10993994 risk allele for prostate cancer results in clinically relevant changes in microseminoprotein-beta expression in tissue and urine. PLoS ONE 5, e13363 (2010). · DOI
  15. Yu, X., Wang, Y., DeGraff, D. J., Wills, M. L. & Matusik, R. J. Wnt/β-Catenin activation promotes prostate tumor progression in a mouse model. Oncogene 30, 1868–1879 (2011). · DOI
  16. Singh, S. K., Banerjee, S., Acosta, E. P., Lillard, J. W. & Singh, R. Resveratrol induces cell cycle arrest and apoptosis with docetaxel in prostate cancer cells via a p53/ p21WAF1/CIP1 and p27KIP1 pathway. Oncotarget 8, 17216–17228 (2017). · DOI · Paper page
  17. Chu, I. M., Hengst, L. & Slingerland, J. M. The Cdk inhibitor p27 in human cancer: prognostic potential and relevance to anticancer therapy. Nat. Rev. Cancer 8, 253–267 (2008). · DOI · Paper page
  18. Fong, P. C. et al. Poly(ADP)-ribose polymerase inhibition: frequent durable responses in BRCA carrier ovarian cancer correlating with platinum-free interval. J. Clin. Oncol. 28, 2512–2519 (2010). · DOI · Paper page
  19. Weinstein, M. H., Signoretti, S. & Loda, M. Diagnostic utility of immunohistochemical staining for p63, a sensitive marker of prostatic basal cells. Mod. Pathol. 15, 1302–1308 (2002). · DOI
  20. Bostwick, D. G. & Qian, J. High-grade prostatic intraepithelial neoplasia. Mod. Pathol. 17, 360–379 (2004). · DOI · Paper page
  21. Chen, W. et al. Tumor protein translationally controlled 1 is a p53 target gene that promotes cell survival. Cell Cycle 12, 2321–2328 (2013). · DOI
  22. Slaughter, D. P., Southwick, H. W. & Smejkal, W. Field cancerization in oral stratified squamous epithelium; clinical implications of multicentric origin. Cancer 6, 963–968 (1953). · DOI · Paper page
  23. Trujillo, K. A. et al. Markers of fibrosis and epithelial to mesenchymal transition demonstrate field cancerization in histologically normal tissue adjacent to breast tumors. Int. J. Cancer 129, 1310–1321 (2011). · DOI
  24. Chandran, U. R. et al. Differences in gene expression in prostate cancer, normal appearing prostate tissue adjacent to cancer and prostate tissue from cancer free organ donors. BMC Cancer 5, 45 (2005). · DOI · Paper page
  25. Aran, D. et al. Comprehensive analysis of normal adjacent to tumor transcriptomes. Nat. Commun. 8, 1077 (2017). · DOI · Paper page
  26. Tsouko, E. et al. Regulation of the pentose phosphate pathway by an androgen receptor-mTOR-mediated mechanism and its role in prostate cancer cell growth. Oncogenesis 3, e103 (2014). · DOI · Paper page
  27. Costello, L. C. & Franklin, R. B. The intermediary metabolism of the prostate: a key to understanding the pathogenesis and progression of prostate malignancy. Oncology 59, 269–282 (2000). · DOI · Paper page
  28. Semenza, G. L. Oxygen sensing, hypoxia-inducible factors, and disease pathophysiology. Annu. Rev. Pathol. 9, 47–71 (2014). · DOI · Paper page
  29. Prasad, P. D., Stanton, J.-A. L. & Assinder, S. J. Expression of the actin-associated protein transgelin (SM22) is decreased in prostate cancer. Cell Tissue Res. 339, 337–347 (2010). · DOI
  30. Choo, S. Y. The HLA system: genetics, immunology, clinical testing, and clinical implications. Yonsei. Med. J. 48, 11–23 (2007). · DOI · Paper page
  31. Consortium, T. U. UniProt: the universal protein knowledgebase. Nucleic Acids Res. 45, D158–D169 (2016).
  32. Abdulkadir, S. A. et al. Impaired prostate tumorigenesis in Egr1-deficient mice. Nat. Med. 7, 101–107 (2001). · DOI · Paper page
  33. Baron, V. et al. Inhibition of Egr-1 expression reverses transformation of prostate cancer cells in vitro and in vivo. Oncogene 22, 4194–4204 (2003). · DOI
  34. Diamandis, E. P., Yousef, G. M., Luo, L. Y., Magklara, A. & Obiezu, C. V. The new human kallikrein gene family: implications in carcinogenesis. Trends Endocrinol. Metab. 11, 54–60 (2000). · DOI · Paper page
  35. Yadav, R. K., Chae, S.-W., Kim, H.-R. & Chae, H. J. Endoplasmic reticulum stress and cancer. J. Cancer Prev. 19, 75–88 (2014). · DOI · Paper page
  36. Li, Q. et al. Keratin 13 expression reprograms bone and brain metastases of human prostate cancer cells. Oncotarget 7, 84645–84657 (2016). · DOI
  37. Yamakawa, M. et al. Protection of thyroid cancer cells by complement-regulatory factors. Cancer 73, 2808–2817 (1994). · doi:10.1002/1097-0142(19940601)73:11<2808::aid-cncr2820731125>3.0.co;2-p
  38. Markiewski, M. M. et al. Modulation of the antitumor immune response by complement. Nat. Immunol. 9, 1225–1235 (2008). · DOI · Paper page
  39. Persad, S. & Dedhar, S. The role of integrin-linked kinase (ILK) in cancer progression. Cancer Metastas. Rev. 22, 375–384 (2003). · DOI · Paper page
  40. Pascal, L. E. et al. Gene expression relationship between prostate cancer cells of Gleason 3, 4 and normal epithelial cells as revealed by cell type-specific transcriptomes. BMC Cancer 9, 452 (2009). · doi:10.1186/1471-2407-9-452
  41. Qian, B.-Z. & Pollard, J. W. Macrophage diversity enhances tumor progression and metastasis. Cell 141, 39–51 (2010). · DOI · Paper page
  42. Fernandez Navarro, J., Sjostrand, J., Salmen, F., Lundeberg, J. & Stahl, P. L. ST Pipeline: an automated pipeline for spatial mapping of unique transcripts. Bioinformatics. 33, 2591–2593 (2017). · DOI
  43. van der Maaten, L. J. P. & Hinton, G. E. Visualizing high-dimensional data using t-SNE. J. Mach. Learn. Res. 9, 2579–2605 (2008).
  44. Jaccard, P. Étude comparative de la distribution florale dans une portion des Alpes et des Jura. Bull. Soc. Vaud. Des. Sci. Nat. 37, 547–579 (1901).
  45. Oksanen, J. et al. Vegan: community ecology package. R. Package Version 2, 4–6 (2018).
  46. Paradis, E., Claude, J. & Strimmer, K. APE: analyses of phylogenetics and evolution in R language. Bioinformatics 20, 289–290 (2004). · DOI · Paper page
  47. Ogris, C., Helleday, T. & Sonnhammer, E. L. L. PathwAX: a web server for network crosstalk based pathway annotation. Nucleic Acids Res. 44, W105–W109 (2016). · DOI
  48. Kanehisa, M. & Goto, S. KEGG: kyoto encyclopedia of genes and genomes. Nucleic Acids Res. 28, 27–30 (2000). · DOI · Paper page
  49. Lun, A. T. L., McCarthy, D. J. & Marioni, J. C. A step-by-step workflow for low-level analysis of single-cell RNA-seq data with Bioconductor. F1000Res. 5, 2122 (2016).
  50. WELCH, B. L. The generalisation of student’s problems when several different population variances are involved. Biometrika 34, 28–35 (1947).
  51. Miller, C. A., Hampton, O., Coarfa, C. & Milosavljevic, A. ReadDepth: a parallel R package for detecting copy number alterations from short sequencing reads. PLoS ONE 6, e16327 (2011). · DOI · Paper page
  52. Suzuki, R. & Shimodaira, H. Pvclust: an R package for assessing the uncertainty in hierarchical clustering. Bioinformatics 22, 1540 (2006). · DOI · Paper page
  53. Ligges, U. & Maechler, M. scatterplot3d–An R Package for Visualizing Multivariate Data. J. Stat. Software 1, https://doi.org/10.18637/jss.v008.i11 (2003). · DOI · Paper page
  54. Jarick, I. et al. Novel common copy number variation for early onset extreme obesity on chromosome 11q11 identified by a genome-wide analysis. Hum. Mol. Genet. 20, 840–852 (2011). · DOI

Cited by

See all 562

Metadata

Authors
Berglund, E., Maaskola, J., Schultz, N., Friedrich, S., Marklund, M., Bergenstråhle, J., Tarish, F., Tanoglidi, A., Vickovic, S., Larsson, L., Salmén, F., Ogris, C., Wallenborg, K., Lagergren, J., Ståhl, P., Sonnhammer, E., Helleday, T., & Lundeberg, J.
Venue
Nature Communications
Published
2018-06-20
Volume
9
Issue
1
Pages
2419-2419
ISSN
2041-1723 (ISSN-L)
OpenAlex
W2808465642
Cited by
562
References
19
FWCI
13.26
Type
journal article
Language
en
Open access
gold
Licence

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Spatial maps of prostate cancer transcriptomes reveal an unexplored landscape of heterogeneity. https://app.cochat.ai/papers/10.1038/s41467-018-04724-5
The paper
Berglund, E., Maaskola, J., Schultz, N., Friedrich, S., Marklund, M., Bergenstråhle, J., Tarish, F., Tanoglidi, A., Vickovic, S., Larsson, L., Salmén, F., Ogris, C., Wallenborg, K., Lagergren, J., Ståhl, P., Sonnhammer, E., Helleday, T., & Lundeberg, J. (2018). Spatial maps of prostate cancer transcriptomes reveal an unexplored landscape of heterogeneity. Nature Communications. https://doi.org/10.1038/s41467-018-04724-5

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.